| HOME >> BIOLOGY >> TECHNOLOGY |
NEW ORLEANS, La. A promising new technique has been developed that will enable more accurate non-invasive positron emission tomography (PET) imaging of new cells injected into the body, according to researchers at SNM's 55th Annual Meeting. The new technique, which involves engineering antibody fragments to act as reporter genesor markers that signal cells of interest for PET imaging purposescould significantly advance the study of genetically engineered cells to treat diseases.
"Genetic cell engineering is the focus of intense research in almost all areas of medicine and shows great promise for treatment of common illnesses such as heart disease, diabetes, and Parkinson's disease and other neurodegenerative disorders," said Wolfgang Weber, lead researcher of the study, Cell Surface Expression of an Engineered Antibody as a PET Reporter Gene for In Vivo PET Imaging, which was performed at the Department of Molecular and Medical Pharmacology at UCLA in collaboration with the Department of Chemistry at UC Davis.
However, despite intense efforts, researchers have few solid, noninvasive methods for accurately tracking the location, function and viability of small numbers of transplanted cells. "Our research shows that using antibodies as reporter genes in PET imaging provides these capabilities and could contribute to improved treatment of a number of potentially devastating diseases," added Weber, now professor of nuclear medicine at the University of Freiburg, Germany.
To improve PET imaging in this area, researchers have been studying the use of reporter geneprobe combinations. With this technique, cells are created to synthesize a protein that binds to or metabolizes radioactive reporter probes that are injected into the body and detected with PET imaging technology. However, most available reporter gene combinations are not aptly sensitive or specific and have significant limitations in terms of tracking the cells of interest to res
'/>"/>
| Contact: Amy Shaw ashaw@snm.org 703-652-6773 Society of Nuclear Medicine Source:Eurekalert |
Related biology technology :
1. Michigan Tech scientist models molecular switch
2. 3M Discontinues Collaboration with Gen-Probe to Develop Molecular Tests for Healthcare-Associated Infections
3. Molecular changes in brain fluid give insight into brain-damaging disease
4. Xceed Molecular Grants Gen-Probe License to Xceeds Flow-Thru Chip(R) Technology for Multiplex Molecular Diagnostics
5. Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics
6. Xceed Molecular Features Ziplex(R) Automated Gene-Expression System at the Biomarker World Congress, Booth 16
7. Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop(TM) II Molecular HIV Co-receptor Tropism Assay
8. SimBioSys Utilizes Revolutionary Hardware Technology to Open New Frontiers in Molecular Modeling
9. DermTech Study on Melanoma Molecular Diagnostic to Be Presented at AACR
10. Amsterdam Molecular Therapeutics Part of Next Biotech Index
11. Molecular Vision and Acrongenomics Unable to Reach Agreement on the Acquisition of Molecular Vision
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |